Easing the Disease Burden of Patients with Atopic Dermatitis Annenberg Center for Health Sciences
-
- Health & Fitness
Atopic dermatitis (AD) is a skin condition with substantial direct and indirect effects on patients. Guidelines for the management of AD were published in 2014, and while many of the tenets of basic AD skin care are well established, patients with AD are still not achieving optimal disease control in real-world practice. In this activity, Dr. Jonathan Silverberg reviews the burden of AD and the unmet needs within AD management today. Components of basic skin care from the 2014 guidelines are reviewed, followed by the most recent data supporting approved therapies and newly emerging oral and to
-
Emerging Therapies: Phase 3 Efficacy & Safety Data
JAK-STAT inhibitors: oral and topical
JAK-STAT inhibitors vs dupilumab
IL-13 antagonists
IL-31 antagonists -
AD Therapies Approved After 2014 AAD Guidelines
Mechanism of action, indication, efficacy, and safety
Dupilumab
Crisaborole -
Adherence to Evidence-Based Guidelines
2014 AAD Guidelines
Recommendations for topical therapies
Recommendations for phototherapy -
Components of Basic AD Care
Role of bathing and moisturizers
Role of topical corticosteroids -
Unmet Needs in AD Care
Direct and indirect effects of AD
Discordance in disease burden between providers and patients
Rates of inadequate disease control